Aurobindo gets US FTC nod to acquire Lannett Co for $250 million | Hyderabad News
Hyderabad: Aurobindo Pharma’s US arm, Aurobindo Pharma USA, has received approval from the US Federal Trade Commission to acquire Lannett Company LLC in a $250 million transaction, clearing a key regulatory hurdle for a deal that is expected to close before the end of June 2026.The buy is valued on a cash-free, debt-free basis and…